Patents by Inventor Andreas Paul Peschel

Andreas Paul Peschel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-staphylococcal antibodies
    Patent number: 9873733
    Abstract: This disclosure generally relates to antibodies or fragments thereof which interact with the bacterial protein MprF. The disclosure further discloses antibodies, which bind to specific extracellular motifs of MprF. The disclosure further relates to therapeutics comprising MprF-specific antibodies and methods of treatment using MprF-specific antibodies or fragments thereof.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: January 23, 2018
    Assignees: MORPHOSYS AG., UNIVERSITAETSKLINIKUM TUEBINGEN
    Inventors: Christoph Michael Ernst, Andreas Paul Peschel, Alexandra Kraus, Michael Tesar
  • ANTI-STAPHYLOCOCCAL ANTIBODIES
    Publication number: 20150368323
    Abstract: This disclosure generally relates to antibodies or fragments thereof which interact with the bacterial protein MprF. The disclosure further discloses antibodies, which bind to specific extracellular motifs of MprF. The disclosure further relates to therapeutics comprising MprF-specific antibodies and methods of treatment using MprF-specific antibodies or fragments thereof.
    Type: Application
    Filed: December 20, 2013
    Publication date: December 24, 2015
    Inventors: Christoph Michael ERNST, Andreas Paul PESCHEL, Alexandra KRAUS, Michael TESAR
  • Nucleic acids encoding (poly) peptides having chips activity
    Patent number: 7081513
    Abstract: The invention relates to nucleic acid molecules encoding (poly)peptides having chemotaxis inhibiting (poly)peptides CHIPS activity, to recombinant vectors harboring such molecules, and the host cells carrying the vectors. The invention further relates to methods for preparing recombinant (poly)peptides having CHIPS activity and to the use of such recombinant (poly)peptides having CHIPS activity for diagnosis, prophylaxis and treatment, such as the treatment of inflammation reactions and HIV. In addition, the invention provides therapeutic and diagnostic compositions comprising as the active ingredient the (poly)peptide having CHIPS activity.
    Type: Grant
    Filed: January 8, 2001
    Date of Patent: July 25, 2006
    Assignee: Alligator Bioscience AB
    Inventors: Johannes Antonius Gerardus Van Strijp, Cornelis Petrus Maria Van Kessel, Andreas Paul Peschel
  • Nucleic acids encoding (poly) peptides having chips activity
    Publication number: 20030175881
    Abstract: The invention relates to nucleic acid molecules encoding (poly)peptides having CHIPS activity, to recombinant vectors harboring such molecules, and the host cells carrying the vectors. The invention further relates to methods for preparing recombinant (poly)peptides having CHIPS activity and to the use of such recombinant (poly)peptides having CHIPS activity for diagnosis, prophylaxis and treatment, such as the treatment of inflammation reactions and HIV. In addition the invention provides therapeutic and diagnostic compositions comprising as the active ingredient the (poly)peptide having CHIPS activity.
    Type: Application
    Filed: January 16, 2003
    Publication date: September 18, 2003
    Inventors: Johannes Antonius Gerardus Van Strijp, Cornelis Petrus Maria Van Kessel, Andreas Paul Peschel